Rapid loss of motility of Helicobacter pylori in the gastric lumen in vivo.
The human pathogen Helicobacter pylori has infected more than half of the world's population. Nevertheless, the first step of infection, the acute colonization of the gastric mucus, is poorly understood. For successful colonization, H. pylori must retain active motility in the gastric lumen until it reaches the safety of the mucus layer. To identify the factors determining the acute colonization, we inserted bacteria into the stomach of anesthetized Mongolian gerbils. We adjusted the gastric juice to defined pH values of between 2.0 and 6.0 by using an autotitrator. Despite the fact that Helicobacter spp. are known to survive low pH values for a certain time in vitro, the length of time that H. pylori persisted under the assay conditions within the gastric juice in vivo was remarkably shorter. In the anesthetized animal we found H. pylori to be irreversibly immotile in less than 1 min at lumen pH values of 2 and 3. At pH 4 motility was lost after 2 min. However, the period of motility increased to more than 15 min at pH 6. Blocking pepsins in the gastric lumen in vivo by using pepstatin significantly increased the period of motility. It was possible to simulate the rapid in vivo immotilization in vitro by adding pepsins. We conclude that pepsin limits the persistence of H. pylori in the gastric chymus to only a few minutes by rapidly inhibiting active motility. It is therefore likely that this short period of resistance in the gastric lumen is one of the most critical phases of Helicobacter infection.
Schreiber
Sören
S
Institut für Physiologie, MA 2/149, Ruhr-Universitaet Bochum, Universitaetsstrasse 150, D-44801 Bochum, Germany. soeren.schreiber@rub.de
Bücker
Roland
R
Groll
Claudia
C
Azevedo-Vethacke
Marina
M
Garten
Désirée
D
Scheid
Peter
P
Friedrich
Susanne
S
Gatermann
Sören
S
Josenhans
Christine
C
Suerbaum
Sebastian
S
D000818:Animals; D005753:Gastric Mucosa / Q000382:microbiology*; D005849:Gerbillinae; D016481:Helicobacter Infections / Q000382:microbiology; D016480:Helicobacter pylori / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009068:Movement; D010434:Pepsin A / Q000494:pharmacology; D010436:Pepstatins / Q000494:pharmacology; D013997:Time Factors
D010436:Pepstatins; D010434:Pepsin A; C031375:pepstatin
Dig Dis Sci. 1999 Feb;44(2):257-65
10063909
Infect Immun. 2002 Apr;70(4):1984-90
11895962
J Bacteriol. 1991 Mar;173(6):1920-31
2001995
J Gen Physiol. 1938 Sep 20;22(1):79-89
19873094
Scand J Gastroenterol. 1967;2(4):257-60
4865176
Klin Wochenschr. 1979 Jul 15;57(14):711-8
381770
Adv Exp Med Biol. 1995;362:201-10
8540320
Arch Dis Child. 2001 Mar;84(3):273-6
11207184
Am J Dig Dis. 1969 Jun;14(6):400-14
4892100
N Engl J Med. 2002 Oct 10;347(15):1175-86
12374879
Am J Physiol. 1997 Jan;272(1 Pt 1):G63-70
9038877
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5024-9
15044704
J Bacteriol. 2002 Jun;184(11):3053-60
12003947
Am J Pathol. 1999 Mar;154(3):951-60
10079274
Biochem Pharmacol. 1980 Aug 15;29(16):2205-12
6775634
Klin Wochenschr. 1979 Jul 15;57(14):719-24
381771
Gut. 1996 Jul;39(1):54-9
8881809
Essays Biochem. 1981;17:52-84
6795036
J Med Microbiol. 1992 Aug;37(2):123-7
1629897
Gastroenterology. 1998 Sep;115(3):642-8
9721161
J Dairy Sci. 1976 Aug;59(8):1398-400
783220
Infect Immun. 1999 Oct;67(10):5151-6
10496889
N Engl J Med. 1996 Apr 18;334(16):1018-22
8598839
Infect Immun. 1996 Jul;64(7):2445-8
8698465
Gastroenterology. 1987 Jul;93(1):77-84
3556306
Int J Epidemiol. 1995 Oct;24(5):875-87
8557443
Gastroenterology. 1985 Jun;88(6):1842-51
3996841
Helicobacter. 2000 Dec;5(4):206-14
11179985
Int J Med Microbiol. 2002 Mar;291(8):605-14
12008914